Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07554404 · ClinicalTrials.gov registry record
Comparison of Maximal Oxygen Uptake Obtained Via Seismofit and Cardiopulmonary Exercise Test
A clinical trial, sponsored by Salisbury University.
- Completed
- Registry status
- 30
- Enrollment target
NCT07554404: Completed study, sponsored by Salisbury University.
NCT07554404 is a clinical trial that has completed, run by Salisbury University. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07554404 has completed, sponsored by Salisbury University.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
This study aims to validate the Ventriject Seismofit device by comparing VO2 Max obtained via the Seismofit and traditional Cardiopulmonary Exercise Testing.
Primary Outcome
Maximal oxygen uptake obtained via Cardiopulmonary Exercise Test on a cycle, as well as the Seismofit at rest.
Interventions
- OTHER VO2 Max
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-10-09 |
| Est. Completion | 2025-12-05 |
What the finished NCT07554404 record still lists
NCT07554404 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which VO2 Max is the first listed.
NCT07554404 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07554404 about?
NCT07554404 is a clinical study titled "Comparison of Maximal Oxygen Uptake Obtained Via Seismofit and Cardiopulmonary Exercise Test". This study aims to validate the Ventriject Seismofit device by comparing VO2 Max obtained via the Seismofit and traditional Cardiopulmonary Exercise Testing.
What is the current status of trial NCT07554404?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2025-10-09. Estimated completion is 2025-12-05.
What interventions are being tested in trial NCT07554404?
The interventions under investigation include: VO2 Max (OTHER).
Who is sponsoring clinical trial NCT07554404?
This trial is sponsored by Salisbury University, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI